What is the mechanism for acute hemolysis occurring in some patients after intravenous anti-D therapy for immune thrombocytopenic purpura?

Transfusion

Volumn 49, Issue 6, 2009, Pages 1026-1031

  Garratty, George ^a  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; HAPTOGLOBIN; RHESUS D ANTIBODY;

ALLOIMMUNITY; BLOOD CLOTTING; BLOOD COMPONENT; EDITORIAL; ERYTHROCYTE MEMBRANE; ERYTHROCYTE TRANSFUSION; HEMOGLOBINURIA; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IN VITRO STUDY; IN VIVO STUDY; SIDE EFFECT;

ACUTE DISEASE; ANEMIA, HEMOLYTIC, AUTOIMMUNE; COMPLEMENT ACTIVATION; HEMOGLOBINURIA; HEMOLYSIS; HUMANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RHO(D) IMMUNE GLOBULIN;

EID: 66549102579     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02216.x     Document Type: Editorial

References (42)

1. Salama A, Mueller-Eckhardt C, Kiefel V. Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet 1983 2 : 193 5.
2. o(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol 1986 22 : 241 50.
3. Bussel JB, Graziano JN, Kimberly RP, Pahwa S, Aledort LM. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanisms of effect. Blood 1991 77 : 1884 93.
4. Andrew M, Blanchette VS, Adams M, Ali K, Barnard D, Chan KW, De Veber LB, Esseltine D, Israels S, Korbrinsky N, Luke B, Milner RA, Woloski BM, Vegh P. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr 1992 120 : 523 7.
5. Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, Milner R, Ali K, Barnard D, Bernstein M, Chan KW, Esseltine D, deVeber B, Israels S, Kobrinksy N, Luke B. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994 344 : 703 7.
6. Scaradavou A, Woo B, Woloski BM, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 1997 89 : 2689 700.
7. Barbolla L, Nieto S, Llamas P, Contreras M, Lubenko A, Garner S. Severe immune haemolytic anaemia caused by intravenous immunoglobulin anti-D in the treatment of autoimmune thrombocytopenia. Vox Sang 1993 64 : 184 5.
8. Hong F, Ruiz R, Price H, Griffiths A, Malinoski F, Woloski M. Safety profile of WinRho anti-D. Semin Hematol 1998 35 : 9 13. (Pubitemid 28136662)
9. Gaines AR. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rho(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 2000 95 : 2523 9.
10. Kees-Folts D, Abt AB, Domen RE, Freilberg AS. Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura. Pediatr Nephrol 2002 17 : 91 6.
11. Chun NS, Savani B, Seder RH, Taplin ME. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura. Am J Hematol 2003 74 : 276 9.
12. Karp J, Ness P. Acute renal failure with hemolysis in a mismatched transfusion recipient treated with RhIG. Transfusion. In press 2009.
13. Rewald E, Francischetti MM. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP). Transfus Apher Sci 2004 30 : 105 10.
14. Gaines AR. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho(D) immune globulin intravenous administration for immune thrombocytopenic purpura. Blood 2005 106 : 1532 7.
15. Dacie JV. The haemolytic anaemias. Congenital and acquired. Part I - the congential anemias. 2nd ed. New York : Grune and Stratton 1960. p. 6.
16. Dacie JV. The haemolytic anaemias. Congenital and acquired. Part II - the auto-immune haemolytic anaemias. 2nd ed. New York : Grune and Stratton 1962. p. 606.
17. o(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model. Transfusion. 2009 49 : 1050 8.
18. Waller M, Lawler SD. A study of the properties of the Rhesus antibody (Ri) diagnostic for the rheumatoid factor and its application to Gm grouping. Vox Sang 1962 7 : 591 606.
19. Ayland J, Horton MA, Tippett P, Waters AH. Complement binding anti-D made in a Du variant woman. Vox Sang 1978 34 : 40 2.
20. Kline WE, Sullivan CM, Pope M, Bowman RJ. An example of a naturally occurring anti-cE (Rh27) that binds complement. Vox Sang 1982 43 : 335 9.
21. Rosse WF, Parker J. Fixation of the first component of complement (C′1a) by human antibodies. J Clin Invest 1968 47 : 2430 45.
22. Freedman J, Massey A, Chaplin H, Monroe MC. Assessment of complement binding by anti-D and anti-M antibodies employing labeled antiglobulin antibodies. Br J Haematol 1980 45 : 309 18.
23. Klun MJ, Muschel LH. Complement fixation by the anti-Rho (D) antibody. Nature 1966 212 : 159 61.
24. Hidalgo C, Romano EL, Linares J, Suarez G. Complement fixation by Rh blood group antibodies. Transfusion 1979 19 : 250 4.
25. Jaffe CJ. NIH Conference. Pathophysiology of immune hemolytic anemia. Ann Intern Med 1977 87 : 220 1.
26. Hughes-Jones N, Ghosh S. Anti-D-coated Rh-positive red cells will bind the first component of the complement pathway, C1q. FEBS Lett 1981 128 : 318 20.
27. Fink DJ, Petz LD, Black MB. Serum haptoglobin. A valuable diagnostic aid in suspected hemolytic transfusion reaction. JAMA 1967 199 : 615 8.
28. Masouredis SP, Chaplin H Jr. Transfusion management of autoimmune hemolytic anemia. In : Chaplin H Jr., editor. Immune hemolytic anemias. New York : Churchill Livingstone 1985. p. 177 205.
29. Jandl JH, Jones AR, Castle WB. The destruction of red cells by antibodies in man. I. Observations on the sequestration and lysis of red cells altered by immune mechanisms. J Clin Invest 1957 36 : 1428 59.
30. Klein HG, Anstee DJ. Mollison's blood transfusion in clinical medicine. 11th ed. Malden (MA) : Blackwell 2005.
31. Wiener AS, Peters HR. Hemolytic reactions following transfusions of blood of the homologous group, with three cases in which the same agglutinogen was responsible. Ann Intern Med 1940 13 : 2306 22.
32. Vogel P, Rosenthal N, Levine P. Hemolytic reactions as a result of isoimmunization following repeated transfusions of homologous blood. Am J Clin Pathol 1943 13 : 1 11.
33. Coburn RF, Kane PB. Maximal erythrocyte and hemoglobin catabolism. J Clin Invest 1968 47 : 1435 46.
34. Garratty G. The James Blundell Award Lecture 2007: do we really understand immune red cell destruction? Transfus Med 2008 18 : 321 34.
35. Brain MC, Prevost JM, Pihl CE, Brown CB. Glycophorin A-mediated haemolysis of normal human erythrocytes: evidence of antigen aggregation in the pathogenesis of immune haemolysis. Br J Haematol 2002 118 : 899 908.
36. Nardi M, Feinmark SJ, Hu L, Li Z, Karpatkin S. Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidate pathway. J Clin Invest 2004 113 : 973 80.
37. Coopamah MD, Freedman J, Semple JW. Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist. Blood 2003 2862 7.
38. Lee JM, Chan K, Kan YW, Johnson JA. Targeted disruption of Nrf2 causes regenerative immune-mediated hemolytic anemia. Proc Natl Acad Sci U S A 2004 101 : 9751 6.
39. Garratty G, Arndt P, Postoway N, Nance S. Severe hemolytic transfusion reactions associated with antibodies not detectable by routine methods [abstract]. Transfusion 1996 36 : 23S.
40. Tarentino MD, Bussel JB, Cines DB, McCrae KR, Gernscheimer T, Liebman HA, Wong WY, Kulkarni R, Grabowski E, McMillan R. A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP) [letter to the editor]. Blood 2007 109 : 5527. (Pubitemid 46890578)
41. Rushdin J, Rumsey DH, Ewing CA, Sandler SG. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin. Transfusion 2000 40 : 551 4.
42. Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol 2005 42 : 137 44.